Action Oncology Pharma (ID) - ONPH

Oncology Pharma Inc (ID) (ONPH) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

0,0502

( -28,29% )

Prix Achat

0,0501

Prix Vente

0,07

Volume échangé

23 540

0,0502 Fourchette du Jour 0,07

0,000001 Plage de 52 semaines 0,364

Cap du marché

1,941M

Clôture Veille

0,07

Ouverture

0,0698

Dernière Transaction

251

0.0502

Dernière heure de transaction

Volume financier

US$ 1 449

VWAP

0,061571

Volume moyen (3 m)

US$ 62 906

Actions en circulation

38 663 215

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

Bénéfice par action (BPA)

Chiffre d'affairess (LTM)

10,21k

Bénéfice net (LTM)

186,04k

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc... Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California. Show more

Secteur

Healthcare

Industrie

Biotechnology & Life Sciences

Site Web

www.oncology-pharma.com

Siège social

San Francisco, United States

Fondé

1993

Oncology Pharma Inc (ID) est coté dans le secteur Healthcare de la OTC Markets avec le ticker ONPH. Le dernier cours de clôture d'Oncology Pharma (ID) était de US$0,07. Au cours de la dernière année, les actions de Oncology Pharma (ID) ont été négociées dans une fourchette de prix de US$ 0,000001 à US$ 0,364.

Oncology Pharma (ID) compte actuellement 38 663 215 actions en circulation. La capitalisation boursière d'Oncology Pharma (ID) est de US$1,94 million.

Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion...

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery...

Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development

Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for...

Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development

Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development ...

Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer

Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer San Francisco, CA -- April 13, 2022...

Oncology Pharma Reports on Progress with Ribera Solutions

SAN FRANCISCO, CA -- March 2, 2022 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK: ONPH) - Oncology Pharma, Inc. ("The Company") is...

Oncology Pharma Releases Further Feasibility Studies, Data and Capacities

SAN FRANCISCO, CA -- February 23, 2022 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK: ONPH) - Oncology Pharma, Inc. ("The Company...

Oncology Pharma Expands on Feasibility Studies and Data

SAN FRANCISCO, CA -- February 17, 2022 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc...

Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine

San Francisco, CA -- February 14, 2022 -- InvestorsHub NewsWire -- Oncology Pharma, Inc. ("The Company") (OTC PINK:ONPH) and Regen...

Oncology Pharma Gives Update on Technology, Formulation and Data Creation

SAN FRANCISCO, CA – February 8, 2022 – InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK: ONPH) - Oncology Pharma, Inc...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.0198	-28.2857142857	0.07	0.07	0.05	31833	0.06389133	CS
4	0.0017	3.50515463918	0.0485	0.11	0.0485	33594	0.06967565	CS
12	-0.0498	-49.8	0.1	0.15	0.03	36177	0.07681213	CS
26	0.0452	904	0.005	0.364	0.004	37642	0.06557964	CS
52	0.0501	50100	0.0001	0.364	1.0E-6	23698	0.05735937	CS
156	-0.3498	-87.45	0.4	0.43	1.0E-6	16099	0.09087444	CS
260	-30.6748	-99.8366151343	30.725	37.76	1.0E-6	71329	7.52292352	CS

ONPH - Frequently Asked Questions (FAQ)

What is the current Oncology Pharma Inc (ID) share price?

The current share price of Oncology Pharma Inc (ID) is US$ 0,0502

How many Oncology Pharma Inc (ID) shares are in issue?

Oncology Pharma Inc (ID) has 38 663 215 shares in issue

What is the market cap of Oncology Pharma Inc (ID)?

The market capitalisation of Oncology Pharma Inc (ID) is USD 1,94M

What is the 1 year trading range for Oncology Pharma Inc (ID) share price?

Oncology Pharma Inc (ID) has traded in the range of US$ 0,000001 to US$ 0,364 during the past year

What is the cash to sales ratio of Oncology Pharma Inc (ID)?

The cash to sales ratio of Oncology Pharma Inc (ID) is 230,9

What is the registered address of Oncology Pharma Inc (ID)?

The registered address for Oncology Pharma Inc (ID) is 1 Sansome Street, San Francisco, California, 94104

What is the Oncology Pharma Inc (ID) website address?

The website address for Oncology Pharma Inc (ID) is www.oncology-pharma.com

Which industry sector does Oncology Pharma Inc (ID) operate in?

Oncology Pharma Inc (ID) operates in the Biotechnology & Life Sciences sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Oncology Pharma Inc (ID) (ONPH)

Oncology Pharma Inc (ID) (ONPH) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Oncology Pharma Inc (ID)

ONPH Dernières nouvelles

Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development

Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development

Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer

Oncology Pharma Reports on Progress with Ribera Solutions

Oncology Pharma Releases Further Feasibility Studies, Data and Capacities

Oncology Pharma Expands on Feasibility Studies and Data

Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine

Oncology Pharma Gives Update on Technology, Formulation and Data Creation

ONPH - Frequently Asked Questions (FAQ)

ONPH Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Oncology Pharma Inc (ID) (ONPH)

Oncology Pharma Inc (ID) (ONPH) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Oncology Pharma Inc (ID)

ONPH Dernières nouvelles

Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development

Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development

Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer

Oncology Pharma Reports on Progress with Ribera Solutions

Oncology Pharma Releases Further Feasibility Studies, Data and Capacities

Oncology Pharma Expands on Feasibility Studies and Data

Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine

Oncology Pharma Gives Update on Technology, Formulation and Data Creation

ONPH - Frequently Asked Questions (FAQ)

ONPH Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités